About this scholarly article

Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer is a scholarly article available to read on EtoBox.

Publisher

American Chemical Society (ACS)